Inhibitors of immune checkpoints—PD-1, PD-L1, CTLA-4—new opportunities for cancer patients and a new challenge for internists and general practitioners by Wojtukiewicz, Marek Z., Rek, Magdalena M., Karpowicz, Kamil, Górska, Maria, Polityńska, Barbara, Wojtukiewicz, Anna M., Moniuszko, Marcin, Radziwon, Piotr, Tucker, Stephanie C., Honn, Kenneth V.

Get full text

Imbalance in Coagulation/Fibrinolysis Inhibitors Resulting in Extravascular Thrombin Generation in Gliomas of Varying Levels of Malignancy by Wojtukiewicz, Marek Z, Mysliwiec, Marta, Matuszewska, Elwira, Sulkowski, Stanislaw, Zimnoch, Lech, Politynska, Barbara, Wojtukiewicz, Anna M, Tucker, Stephanie C, Honn, Kenneth V

Get full text

Is depression the missing link between inflammatory mediators and cancer? by Polityńska, Barbara, Pokorska, Olga, Wojtukiewicz, Anna M., Sawicka, Magdalena, Myśliwiec, Marta, Honn, Kenneth V., Tucker, Stephanie C., Wojtukiewicz, Marek Z.

Get full text

Tissue factor pathway inhibitor-2 (TFPI-2)—an underappreciated partaker in cancer and metastasis by Wojtukiewicz, Marek Z., Mysliwiec, Marta, Tokajuk, Anna, Kruszewska, Joanna, Politynska, Barbara, Jamroze, Anmbreen, Wojtukiewicz, Anna M., Tang, Dean G., Honn, Kenneth V.

Get full text

It is not just the drugs that matter: the nocebo effect by Wojtukiewicz, Marek Z., Politynska, Barbara, Skalij, Piotr, Tokajuk, Piotr, Wojtukiewicz, Anna M., Honn, Kenneth V.

Get full text

Direct Oral Anticoagulants in Cancer Patients. Time for a Change in Paradigm by Wojtukiewicz, Marek Z, Skalij, Piotr, Tokajuk, Piotr, Politynska, Barbara, Wojtukiewicz, Anna M, Tucker, Stephanie C, Honn, Kenneth V

Get full text

Heterogeneous Expression of Proangiogenic and Coagulation Proteins in Gliomas of Different Histopathological Grade by Wojtukiewicz, Marek Z, Mysliwiec, Marta, Matuszewska, Elwira, Sulkowski, Stanislaw, Zimnoch, Lech, Politynska, Barbara, Wojtukiewicz, Anna M, Tucker, Stephanie C, Honn, Kenneth V

Get full text

Differential Response of MDA-MB-231 and MCF-7 Breast Cancer Cells to In Vitro Inhibition with CTLA-4 and PD-1 through Cancer-Immune Cells Modified Interactions by Grubczak, Kamil, Kretowska-Grunwald, Anna, Groth, Dawid, Poplawska, Izabela, Eljaszewicz, Andrzej, Bolkun, Lukasz, Starosz, Aleksandra, Holl, Jordan M., Mysliwiec, Marta, Kruszewska, Joanna, Wojtukiewicz, Marek Z., Moniuszko, Marcin

Get full text

Pembrolizumab-combination therapy for NSCLC- effectiveness and predictive factors in real-world practice by Knetki-Wróblewska, Magdalena, Dziadziuszko, Rafał, Jankowski, Tomasz, Krawczyk, Paweł, Bryl, Maciej, Stencel, Katarzyna, Wrona, Anna, Bandura, Artur, Smok-Kalwat, Jolanta, Rok-Knapińska, Jolanta, Szydziak-Zwierzyńska, Kinga, Rogoziewicz, Krzysztof, Czyżewicz, Grzegorz, Wójtowicz, Monika, Wojtukiewicz, Marek, Kalinka, Ewa, Wysocki, Piotr J, Łobacz, Mateusz, Milanowski, Janusz, Pawlik, Hubert, Kowalski, Dariusz M, Krzakowski, Maciej

Get full text